AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate
Authors: Davies, TG Tunnah, P Meijer, L Marko, D Eisenbrand, G Endicott, JA Noble, MEM
Citation: Tg. Davies et al., Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate, STRUCTURE, 9(5), 2001, pp. 389-397
Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinodermamathewsi
Authors: Loukaci, A Le Saout, I Samadi, M Leclerc, S Damiens, E Meijer, L Debitus, C Guyot, M
Citation: A. Loukaci et al., Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinodermamathewsi, BIO MED CH, 9(11), 2001, pp. 3049-3054
Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest
Authors: Damiens, E Baratte, B Marie, D Eisenbrand, G Meijer, L
Citation: E. Damiens et al., Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest, ONCOGENE, 20(29), 2001, pp. 3786-3797
Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatinremodeling
Authors: Escargueil, AE Plisov, SY Skladanowski, A Borgne, A Meijer, L Gorbsky, GJ Larsen, AK
Citation: Ae. Escargueil et al., Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatinremodeling, FASEB J, 15(10), 2001, pp. NIL_91-NIL_112
Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium
Authors: Naik, S Kelly, EJ Meijer, L Pettersson, T Sanderson, IR
Citation: S. Naik et al., Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium, J PED GASTR, 32(4), 2001, pp. 449-453
In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humans
Authors: Ouarzane-Amara, M Franetich, JF Pettit, GR Meijer, L Doerig, C Desportes-Livage, I
Citation: M. Ouarzane-amara et al., In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humans, ANTIM AG CH, 45(12), 2001, pp. 3409-3415
Analysis of symptoms of disease after a BHV1 vaccination
Authors: van Wuijckhuise, L Frankena, K van Oijen, MAAJ Meijer, L
Citation: L. Van Wuijckhuise et al., Analysis of symptoms of disease after a BHV1 vaccination, TIJD DIERG, 126(6), 2001, pp. 173-180
Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors
Authors: Wang, D de la Fuente, C Deng, LW Wang, L Zilberman, I Eadie, C Healey, M Stein, D Denny, T Harrison, LE Meijer, L Kashanchi, F
Citation: D. Wang et al., Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors, J VIROLOGY, 75(16), 2001, pp. 7266-7279
Synthesis of a new series of purine derivatives and their anti-cyclin-dependent kinase activities
Authors: Legraverend, M Ludwig, O Leclerc, S Meijer, L
Citation: M. Legraverend et al., Synthesis of a new series of purine derivatives and their anti-cyclin-dependent kinase activities, J HETERO CH, 38(1), 2001, pp. 299-303
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease - A property common to most cycline-dependent kinase inhibitors?
Authors: Leclerc, S Garnier, M Hoessel, R Marko, D Bibb, JA Snyder, GL Greengard, P Biernat, J Wu, YZ Mandelkow, EM Eisenbrand, G Meijer, L
Citation: S. Leclerc et al., Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease - A property common to most cycline-dependent kinase inhibitors?, J BIOL CHEM, 276(1), 2001, pp. 251-260
Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum - Biochemical properties and possible involvement in MAPK regulation
Authors: Dorin, D Le Roch, K Sallicandro, P Alano, P Parzy, D Poullet, P Meijer, L Doerig, C
Citation: D. Dorin et al., Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum - Biochemical properties and possible involvement in MAPK regulation, EUR J BIOCH, 268(9), 2001, pp. 2600-2608
Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors
Authors: Meijer, L Knockaert, M Damiens, E
Citation: L. Meijer et al., Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors, B CANCER, 88(4), 2001, pp. 347-350
Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives inhuman tumour cells
Authors: Marko, D Schatzle, S Friedel, A Genzlinger, A Zankl, H Meijer, L Eisenbrand, G
Citation: D. Marko et al., Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives inhuman tumour cells, BR J CANC, 84(2), 2001, pp. 283-289
Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum
Authors: Harmse, L van Zyl, R Gray, N Schultz, P Leclerc, S Meijer, L Doerig, C Havlik, I
Citation: L. Harmse et al., Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum, BIOCH PHARM, 62(3), 2001, pp. 341-348
Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents
Authors: Meijer, L
Citation: L. Meijer, Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents, DRUG RESIST, 3(2), 2000, pp. 83-88
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors
Authors: Knockaert, M Gray, N Damiens, E Chang, YT Grellier, P Grant, K Fergusson, D Mottram, J Soete, M Dubremetz, JF Le Roch, K Doerig, C Schultz, PG Meijer, L
Citation: M. Knockaert et al., Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors, CHEM BIOL, 7(6), 2000, pp. 411-422
Inhibition of cyclin-dependent kinases, GSK-3 beta and CK1 by hymenialdisine, a marine sponge constituent
Authors: Meijer, L Thunnissen, AMWH White, AW Garnier, M Nikolic, M Tsai, LH Walter, J Cleverley, KE Salinas, PC Wu, YZ Biernat, J Mandelkow, EM Kim, SH Pettit, GR
Citation: L. Meijer et al., Inhibition of cyclin-dependent kinases, GSK-3 beta and CK1 by hymenialdisine, a marine sponge constituent, CHEM BIOL, 7(1), 2000, pp. 51-63
Purification of GSK-3 by affinity chromatography on immobilized axin
Authors: Primot, A Baratte, B Gompel, M Borgne, A Liabeuf, S Romette, JL Jho, EH Costantini, F Meijer, L
Citation: A. Primot et al., Purification of GSK-3 by affinity chromatography on immobilized axin, PROT EX PUR, 20(3), 2000, pp. 394-404
High developmental competence of cattle oocytes maintained at the germinalvesicle stage for 24 hours in culture by specific inhibition of MPF kinaseactivity
Authors: Mermillod, P Tomanek, M Marchal, R Meijer, L
Citation: P. Mermillod et al., High developmental competence of cattle oocytes maintained at the germinalvesicle stage for 24 hours in culture by specific inhibition of MPF kinaseactivity, MOL REPROD, 55(1), 2000, pp. 89-95
2-substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity
Authors: Kunick, C Schultz, C Lemcke, T Zaharevitz, DW Gussio, R Jalluri, RK Sausville, EA Leost, M Meijer, L
Citation: C. Kunick et al., 2-substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity, BIOORG MED, 10(6), 2000, pp. 567-569
Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1
Authors: Jeong, HW Kim, MR Son, KH Han, MY Ha, JH Garnier, M Meijer, L Kwon, BM
Citation: Hw. Jeong et al., Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1, BIOORG MED, 10(16), 2000, pp. 1819-1822
A S/M DNA replication checkpoint prevents nuclear and cytoplasmic events of cell division including centrosomal axis alignment and inhibits activation of cyclin-dependent kinase-like proteins in fucoid zygotes
Authors: Corellou, F Bisgrove, SR Kropf, DL Meijer, L Kloareg, B Bouget, FY
Citation: F. Corellou et al., A S/M DNA replication checkpoint prevents nuclear and cytoplasmic events of cell division including centrosomal axis alignment and inhibits activation of cyclin-dependent kinase-like proteins in fucoid zygotes, DEVELOPMENT, 127(8), 2000, pp. 1651-1660
Chemical inhibitors of cyclin-dependent kinases: preclinical and clinical studies.
Authors: Damiens, E Meijer, L
Citation: E. Damiens et L. Meijer, Chemical inhibitors of cyclin-dependent kinases: preclinical and clinical studies., PATH BIOL, 48(3), 2000, pp. 340-351
Imidazo[2,1-b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition
Authors: Andreani, A Cavalli, A Granaiola, M Leoni, A Locatelli, A Morigi, R Rambaldi, M Recanatini, M Garnier, M Meijer, L
Citation: A. Andreani et al., Imidazo[2,1-b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition, ANTI-CAN DR, 15(6), 2000, pp. 447-452
Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition
Authors: Gussio, R Zaharevitz, DW McGrath, CF Pattabiraman, N Kellogg, GE Schultz, C Link, A Kunick, C Leost, M Meijer, L Sausville, EA
Citation: R. Gussio et al., Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition, ANTI-CAN DR, 15(1), 2000, pp. 53-66
Risultati: 1-25 | 26-45